China
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 25.08 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
2 |
USD 10.87 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
3 |
USD 6.15 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
4 |
USD 5.06 B
|
Dec. 31, 2023 | USD 0.70 | 2.41% |
|
China |
|
5 |
USD 4.14 B
|
Dec. 31, 2023 | USD 0.67 | 1.67% |
|
China |
|
6 |
USD 3.81 B
|
Dec. 31, 2023 | USD 3.45 | 3.36% |
|
China |
|
7 |
USD 2.85 B
|
Dec. 31, 2023 | USD 3.66 | 2.21% |
|
China |
|
8 |
USD 2.76 B
|
Dec. 31, 2023 | USD 2.27 | 3.13% |
|
China |
|
9 |
USD 2.63 B
|
Dec. 31, 2023 | USD 0.34 | 2.88% |
|
China |
|
10 |
USD 2.38 B
|
Dec. 31, 2023 | USD 1.47 | 2.19% |
|
China |
|
11 |
USD 2.28 B
|
Dec. 31, 2023 | USD 0.65 | 2.15% |
|
China |
|
12 |
USD 1.81 B
|
Dec. 31, 2023 | USD 4.26 | 1.90% |
|
China |
|
13 |
USD 1.76 B
|
Dec. 31, 2023 | USD 0.25 | 2.80% |
|
China |
|
14 |
USD 1.66 B
|
Dec. 31, 2023 | USD 7.83 | 2.23% |
|
China |
|
15 |
USD 1.56 B
|
Dec. 31, 2023 | USD 2.34 | 2.64% |
|
China |
|
16 |
USD 1.50 B
|
Dec. 31, 2023 | USD 0.56 | 0.44% |
|
China |
|
17 |
USD 1.36 B
|
Dec. 31, 2023 | USD 1.68 | 2.25% |
|
China |
|
18 |
USD 1.35 B
|
Dec. 31, 2023 | USD 2.91 | 1.87% |
|
China |
|
19 |
USD 1.29 B
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
20 |
USD 1.25 B
|
Dec. 31, 2023 | USD 4.53 | 2.64% |
|
China |
|
21 |
USD 1.21 B
|
Dec. 31, 2023 | USD 5.92 | 1.98% |
|
China |
|
22 |
USD 1.20 B
|
Dec. 31, 2023 | USD 1.46 | 3.48% |
|
China |
|
23 |
USD 1.19 B
|
Dec. 31, 2023 | USD 1.71 | 1.65% |
|
China |
|
24 |
USD 904.23 M
|
Dec. 31, 2023 | USD 1.40 | 3.01% |
|
China |
|
25 |
USD 871.08 M
|
Dec. 31, 2023 | USD 2.26 | 4.12% |
|
China |
|
26 |
USD 864.10 M
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
27 |
USD 862.02 M
|
Dec. 31, 2023 | USD 3.86 | 1.55% |
|
China |
|
28 |
USD 832.88 M
|
Dec. 31, 2023 | USD 2.05 | 4.96% |
|
China |
|
29 |
USD 799.05 M
|
Dec. 31, 2023 | USD 1.10 | 2.94% |
|
China |
|
30 |
USD 760.50 M
|
Dec. 31, 2023 | USD 3.54 | 2.01% |
|
China |
|
31 |
USD 698.70 M
|
Dec. 31, 2023 | USD 0.52 | 4.12% |
|
China |
|
32 |
USD 652.72 M
|
Dec. 31, 2023 | USD 1.47 | 0.94% |
|
China |
|
33 |
USD 627.66 M
|
Dec. 31, 2023 | USD 0.99 | 4.49% |
|
China |
|
34 |
USD 594.67 M
|
Dec. 31, 2023 | USD 0.38 | 3.33% |
|
China |
|
35 |
USD 548.78 M
|
Dec. 31, 2023 | USD 1.34 | 1.74% |
|
China |
|
36 |
USD 529.81 M
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
37 |
USD 503.54 M
|
Dec. 31, 2023 | USD 3.31 | 1.16% |
|
China |
|
38 |
USD 499.32 M
|
Dec. 31, 2023 | USD 7.41 | 1.09% |
|
China |
|
39 |
USD 493.99 M
|
Dec. 31, 2023 | USD 0.85 | 1.48% |
|
China |
|
40 |
USD 471.94 M
|
Dec. 31, 2023 | USD 12.91 | 2.15% |
|
China |
|
41 |
USD 470.75 M
|
Dec. 31, 2023 | USD 0.89 | 4.83% |
|
China |
|
42 |
USD 461.30 M
|
Dec. 31, 2023 | USD 0.61 | 2.08% |
|
China |
|
43 |
USD 452.73 M
|
Dec. 31, 2023 | USD 2.14 | 2.31% |
|
China |
|
44 |
USD 436.72 M
|
Dec. 31, 2023 | USD 1.59 | 4.31% |
|
China |
|
45 |
USD 428.06 M
|
Dec. 31, 2023 | USD 0.51 | 3.91% |
|
China |
|
46 |
USD 427.69 M
|
Dec. 31, 2023 | USD 0.53 | 1.04% |
|
China |
|
47 |
USD 422.41 M
|
Dec. 31, 2023 | USD 9.47 | 1.45% |
|
China |
|
48 |
USD 407.72 M
|
Dec. 31, 2023 | USD 2.16 | 1.67% |
|
China |
|
49 |
USD 397.09 M
|
Dec. 31, 2023 | USD 2.09 | 2.89% |
|
China |
|
50 |
USD 396.93 M
|
Dec. 31, 2023 | USD 2.19 | 4.03% |
|
China |
The Health Care company in China with the highest Receivables is Sinopharm Group Co. Ltd. (HKSE: 1099.HK) at USD 25.08 B.
The Health Care company in China with the lowest Receivables is Zhongzhu Healthcare Holding Co.,Ltd (Shanghai Stock Exchange: 600568.SS) at USD -2.34 M.
The top 10 Health Care companies in China by Receivables are Sinopharm Group Co. Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, Fosun International Limited, C.Q. Pharmaceutical Holding Co., Ltd., Jointown Pharmaceutical Group Co., Ltd, Chongqing Zhifei Biological Products Co., Ltd., China National Accord Medicines Corporation Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, Shenzhen Neptunus Bioengineering Co., Ltd. and China Meheco Group Co., Ltd..
The bottom 10 Health Care companies in China by Receivables are Zhongzhu Healthcare Holding Co.,Ltd, Guangdong Lifestrong Pharmacy Co., Ltd., Jiangsu Bioperfectus Technologies Co., Ltd., CanSino Biologics Inc., Genor Biopharma Holdings Limited, 3SBio Inc., Arrail Group Limited, Beijing Tiantan Biological Products Co., Ltd., AK Medical Holdings Limited and Shanghai Junshi Biosciences Co., Ltd..